Deflazacort API Quality and Documentation Across Global Markets

Deflazacort API Quality Standards & Documentation Requirements

Deflazacort API quality is the backbone of producing high-efficacy corticosteroid drug formulations. As a potent glucocorticoid used in managing inflammatory and autoimmune conditions, Deflazacort Active Pharmaceutical Ingredient (API) demands stringent quality control during synthesis and final release testing. Quality benchmarking typically aligns with global pharmacopeias such as the USP (United States Pharmacopeia), EP (European Pharmacopoeia), and other regulatory standards, ensuring parameters such as assay potency, impurities limit, residual solvents, and microbial purity are within rigorous limits. Robust quality documentation is essential for regulatory compliance; this includes Certificate of Analysis (CoA), Material Safety Data Sheets (MSDS), and detailed batch manufacturing records that trace the API from raw materials to finished documentation. The API’s stability data and ICH (International Council for Harmonisation)-aligned validation reports further bolster its acceptance across diverse regulatory markets. Comprehensive documentation not only ensures patient safety and product consistency but also facilitates smoother interactions with regulators and customers worldwide.

General API Information

Chemical Identity

  • API Name: Deflazacort
  • CAS Number: 14484-47-0
  • Molecular Formula: C₂₅H₃₁NO₆
  • Molecular Weight: ~441.5 g/mol
  • Appearance: White to off-white crystalline powder
  • Synonyms: Calcort, Emflaza

🧪 Chemical & Physical Properties

  • Deflazacort is a synthetic corticosteroid prodrug — chemically related to prednisolone with structural modifications to influence its pharmacological profile.
  • It’s freely soluble in acetic acid and dichloromethane, and sparingly soluble in methanol and acetone.
  • Typically insoluble or very slightly soluble in water — common for many steroid APIs.

💊 Pharmacological Profile

Mechanism of Action:

  • Deflazacort itself is an inactive prodrug. After administration, it’s rapidly converted by esterases into its active metabolite, generally referred to as 21-desacetyldeflazacort, which binds to glucocorticoid receptors to exert anti-inflammatory and immunosuppressive effects.

Therapeutic Class:

  • Glucocorticoid
  • Anti-inflammatory agent
  • Immunosuppressant

⚙️ API Role and Use

  • Deflazacort API is intended for use in pharmaceutical manufacture — not for direct human or veterinary consumption. The API is formulated into finished products such as tablets, dispersible tablets, syrups, or suspensions.
  • Its primary use in formulations is for treating inflammatory and autoimmune conditions, including Duchenne muscular dystrophy (DMD), asthma, rheumatoid arthritis and other allergic disorders, once converted to its active form in the body.

🏭 Manufacturing & Quality Standards

  • High-quality Deflazacort API is typically manufactured in cGMP and ISO-certified facilities, with Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS) provided for each batch.
  • Pharmacopeial standards such as USP/BP/EP may be used for quality benchmarks depending on regulatory requirements.

📦 Handling, Storage, & Safety

 

  • The API should be stored in a cool, dry place, protected from light and moisture to maintain stability and potency.
  • In bulk, Deflazacort is classified as non-dangerous goods, but standard precautions should be used during handling.

Global Supply Chain & Leading Deflazacort API Manufacturers

The global supply chain for Deflazacort API integrates multiple stakeholders — from raw material suppliers to contract manufacturers and logistics partners — all operating under Good Manufacturing Practices (GMP) and international quality norms. Leading API manufacturers focus on scalable production capabilities while maintaining adherence to environmental and safety standards. Efficient sourcing of key intermediates, validated production processes, and real-time supply chain monitoring help mitigate disruptions and ensure consistent API availability for formulation partners. Documentation throughout this supply chain is critical: supplier qualification files, incoming raw material test reports, manufacturing batch records, and finished goods release certificates form the backbone of traceability. Manufacturers who can provide transparent documentation gain trust from both domestic and international pharmaceutical companies that rely on timely Deflazacort API deliveries for their formulations.

Amber Lifesciences Expertise in Deflazacort API & Documentation Excellence

At Amber Lifesciences, our expertise in API manufacturing and regulatory documentation ensures that clients receive premium quality Deflazacort API backed by thorough compliance. With a dedicated quality assurance team, we implement rigorous in-process controls and post-production validation to meet or exceed pharmacopeial standards. Our documentation suite includes comprehensive CoAs, MSDS, stability profiles, and traceable quality records tailored to the requirements of global markets. We leverage advanced analytical technologies and a well-structured quality management system (QMS) to deliver APIs that are consistent, safe, and ready for pharmaceutical formulation.

By aligning with global supply chain norms and offering transparent, detailed documentation, Amber Lifesciences supports pharmaceutical partners in accelerating product development and regulatory approvals. Our commitment to quality and compliance positions us as a trusted manufacturer in the competitive Deflazacort API landscape.